Thorp Clay

Director | Director, 10% Owner

1 company

Good

Trades Analyzed

12M Win Rate

100.0%

Avg 3M Return

+10.1%

Avg 12M Return

+19.4%

Thorp Clay is a Director at Clearside Biomedical, Inc.. Recent SEC Form 4 filings include 1 buy and 25 sells.

Estimated insider holdings value: $56K based on current market prices.

Holdings by Company

CLSDQFeb 24, 2025

Current Shares176.1K

Value$56.4K

Net Activity+3.3K

Bought: 832.7KSold: 829.4K

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%
Sep 15, 2017	CLSDQ Clearside Biomedical, Inc.	Director, 10% Owner	Sell	24,500	$7.52	$184,185.00	-0.2%
Aug 9, 2017	CLSDQ Clearside Biomedical, Inc.	Director, 10% Owner	Sell	24,500	$7.57	$185,490.00	-0.2%
May 19, 2017	CLSDQ Clearside Biomedical, Inc.	Director, 10% Owner	Sell	24,000	$8.36	$200,610.00	-0.3%
May 17, 2017	CLSDQ Clearside Biomedical, Inc.	Director, 10% Owner	Sell	44,485	$8.63	$384,096.38	-0.4%
Apr 19, 2017	CLSDQ Clearside Biomedical, Inc.	Director, 10% Owner	Sell	68,485	$7.46	$510,944.50	-0.6%
Mar 16, 2017	CLSDQ Clearside Biomedical, Inc.	Director, 10% Owner	Sell	68,485	$6.56	$449,543.45	-0.8%
Feb 22, 2017	CLSDQ Clearside Biomedical, Inc.	Director, 10% Owner	Sell	27,000	$7.55	$203,730.00	-0.3%
Feb 17, 2017	CLSDQ Clearside Biomedical, Inc.	Director, 10% Owner	Sell	41,485	$7.60	$315,105.40	-0.3%
Jan 20, 2017	CLSDQ Clearside Biomedical, Inc.	Director, 10% Owner	Sell	68,485	$8.53	$584,001.55	-0.4%
Jun 7, 2016	CLSDQ Clearside Biomedical, Inc.	Director, 10% Owner	Buy	785,714	$7.00	$5,499,998.00	+22.6%